Categories AlphaGraphs, Consumer, Earnings
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today.
Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%.
Net income attributable to Colgate-Palmolive Company was $683 million, or $0.83 per share, compared to $372 million, or $0.45 per share, last year. Base business EPS increased 18% to $0.86.
Revenue and earnings beat estimates, sending the stock rising over 3% in premarket hours on Friday.
For the full year of 2024, the company is raising its net sales growth guidance to 2-5% from the previous range of 1-4%. Organic sales is now expected to grow 5-7% versus the previous outlook of 3-5%. Base business EPS is expected to grow in the mid to high single digits.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report
Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,
J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights
The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs
